On Friday, Mural Oncology plc (NASDAQ: MURA) was -8.13% drop from the session before settling in for the closing price of $1.23. A 52-week range for MURA has been $1.11 – $4.96.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 5.55%. When this article was written, the company’s average yearly earnings per share was at 36.39%. With a float of $15.34 million, this company’s outstanding shares have now reached $17.10 million.
The extent of productivity of a business whose workforce counts for 116 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Mural Oncology plc (MURA) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Mural Oncology plc stocks. The insider ownership of Mural Oncology plc is 10.97%, while institutional ownership is 52.81%. The most recent insider transaction that took place on Mar 04 ’25, was worth 14,491. Before that another transaction happened on Mar 05 ’25, when Company’s insider sold 1,469 for $3.45, making the entire transaction worth $5,068. This insider now owns 73,564 shares in total.
Mural Oncology plc (MURA) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.51 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 36.39% per share during the next fiscal year.
Mural Oncology plc (NASDAQ: MURA) Trading Performance Indicators
You can see what Mural Oncology plc (MURA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 5.83.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -7.58, a number that is poised to hit -1.80 in the next quarter and is forecasted to reach -3.04 in one year’s time.
Technical Analysis of Mural Oncology plc (MURA)
The latest stats from [Mural Oncology plc, MURA] show that its last 5-days average volume of 0.4 million was superior to 0.27 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 4.76%. Additionally, its Average True Range was 0.29.
During the past 100 days, Mural Oncology plc’s (MURA) raw stochastic average was set at 0.55%, which indicates a significant decrease from 0.62% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 387.91% in the past 14 days, which was higher than the 164.37% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.4352, while its 200-day Moving Average is $3.4158. Now, the first resistance to watch is $1.2133. This is followed by the second major resistance level at $1.2967. The third major resistance level sits at $1.3433. If the price goes on to break the first support level at $1.0833, it is likely to go to the next support level at $1.0367. Assuming the price breaks the second support level, the third support level stands at $0.9533.
Mural Oncology plc (NASDAQ: MURA) Key Stats
There are 17,228K outstanding shares of the company, which has a market capitalization of 19.47 million. As of now, sales total 0 K while income totals -128,510 K. Its latest quarter income was 0 K while its last quarter net income were -34,270 K.
